Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer.
about
Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry.Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerEffects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysisOutcome of triple-negative breast cancer in patients with or without deleterious BRCA mutationsWorse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression.Tumor characteristics and prognosis in familial breast cancer.Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer.Long-term treatment after preoperative high-dose chemotherapy in a lactating breast cancer patient.Breast cancer family history leads to early breast cancer detection and optimal management.The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.The role of BRCA status on prognosis in patients with triple-negative breast cancer.Survivial Outcomes in BRCA1 or BRCA2 Mutation Carriers and the Influence of Triple-Negative Breast Cancer Subtype
P2860
Q30836057-A11FC629-1364-402B-B548-F25C3E213B42Q34059765-E6625188-11E7-4C08-A803-8F5705E03E19Q34103963-C493C7F0-EC98-4A17-8AB4-7E55D7954222Q34625335-96DD9D86-CF23-4C88-8551-E46D3C60F284Q34860429-EFC70B29-6D68-4721-9066-5ABC48158CE1Q35100315-04590317-EA7B-4187-8B74-2C0094EAB776Q35224593-6EDD78ED-D73B-4412-897D-2059988E0983Q36009795-1660C150-7575-43B4-8D39-31CA73724BC0Q36207051-6A71C49B-4547-4703-8C1C-2DE5B7D96C97Q37328846-AB541434-D682-4F19-89FD-F8A8225AF64AQ37388751-F73EB30B-6D01-4645-AB52-F52E045138C4Q38148063-0E780A15-7E57-46F8-82E1-80FF711B99D4Q38656153-AC71F4D3-4494-4E50-AE0E-ACA997A24C77Q40292155-CCD5C689-29BE-4240-A937-AAA3C53711DAQ47097677-B0DAA810-02D6-44D5-A9C6-97E8A96ED637Q58694347-562339D3-A8D0-43C0-8888-9FF65E74B804
P2860
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Favourable ten-year overall su ...... y of hereditary breast cancer.
@ast
Favourable ten-year overall su ...... y of hereditary breast cancer.
@en
Favourable ten-year overall su ...... y of hereditary breast cancer.
@nl
type
label
Favourable ten-year overall su ...... y of hereditary breast cancer.
@ast
Favourable ten-year overall su ...... y of hereditary breast cancer.
@en
Favourable ten-year overall su ...... y of hereditary breast cancer.
@nl
prefLabel
Favourable ten-year overall su ...... y of hereditary breast cancer.
@ast
Favourable ten-year overall su ...... y of hereditary breast cancer.
@en
Favourable ten-year overall su ...... y of hereditary breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Favourable ten-year overall su ...... y of hereditary breast cancer.
@en
P2093
Claudia Cirilli
Giovanna Cavazzini
Giuseppe Pasini
Isabella Marchi
Laura Cortesi
Massimo Federico
Veronica Medici
P2860
P2888
P356
10.1186/1471-2407-10-90
P407
P577
2010-03-10T00:00:00Z
P5875
P6179
1027598338